News Detail
New Delhi, 11 Aug 2023: The National Pharmaceutical Pricing Authority (NPPA) has received a total of 226 intimations under Form IV for discontinuation of scheduled formulations from the market between April 1, 2020 and July 31, 2023 and has approved 157 cases.
Accordin......
View Details
Source : Pharmabiz
National Pharmaceutical Pricing Authority
NPPA
Form IV
Lok Sabha
DPCO 2013
Schedule-II
Baxter Pharmaceuticals
Sedoz
midazolam
Sucrofer
iron sucrose
Zepita
piperacillin
tazobactam
Zepita
Panisa
pantoprazole
Profol
propofol
Pfizer
Cyklokapron
Related News
- In Sriganganagar and Raisinghnagar, One family is running a dirty business of drugs (22-09-2023)
- Four persons involved in cheating in the name of fake pharma company arrested (22-09-2023)
- Two patients' health deteriorated after injection in Halat Hospital, Kanpur (22-09-2023)
- SEC recommends permission for phase I trial of Cadila Pharma's VZV vaccine (22-09-2023)
- Adding preservatives to ayurvedic medicine will change the classification of medicine (22-09-2023)
- 50 children fell ill after taking filariasis medicine in Purnia (21-09-2023)
- Two smuggling gang youths arrested, one thousand intoxicating pills recovered (21-09-2023)
- FSDA Meerut team raided Transport Godown in Hapur to check consignment of Phensedyl (21-09-2023)
- NMC gets WFME Recognition for 10 Years (21-09-2023)
- Govt approved ₹480 crore to develop talent pool for medical devices sector (21-09-2023)